Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Diabetes Health Reference Charts
Insulin Archives
Print | Email | Share | Comments (0)

Finn Researchers Find That Early Childhood Metabolic Disturbances Predict Later Onset of Type 1

Dec 22, 2008

The research used metabolomics, the systematic study of the chemical “fingerprints” in cells, tissues, and biofluids, taking into account both physiology and the environment

Finnish scientists have reported that children who develop type 1 diabetes experience disturbances in their lipid and amino acid metabolism months or years before the onset of the disease. Their finding of distinct markers that precede the disease could lead to treatments designed to prevent the body's autoimmune system from attacking the pancreatic insulin-producing cells.

Before the scientists published their study in the December 15, 2008, issue of the Journal of Experimental Medicine, the earliest reliable indicators of potential type 1 had been islet autoantibodies, which show up as the body begins to make an autoimmune assault on pancreatic beta cells. Unfortunately, although their appearance can precede full-blown type 1 by months or years, islet autoantibodies sometimes fail to materialize until it's already too late to intervene with preventive therapies. 

The Finns found that people who develop type 1 are born with reduced serum levels of succinic acid and phosphatidylcholine. Later, they experience reduced levels of triglycerides and antioxidant ether phospholipids. Several months before developing immunity to their own pancreatic beta cells, they experience increased levels of lysophosphatidylcholines-a kind of acid-that produce inflammation.

Because the sequence and agents involved are so clear, the scientists hope to eventually develop preventive strategies based on them. Their research used metabolomics, the systematic study of the chemical "fingerprints" in cells, tissues, and biofluids, taking into account both physiology and the environment. Because a person's metabolism can be affected by age, lifestyle, food, and intestinal microbes, plotting their effects could lead to changes or adjustments that stave off type 1.

Finnish interest in diabetes is a response to that country's high incidence of type 1: One out of every 120 Finnish children develops the disease, and the rate of incidence is increasing yearly. The country is expecting the number of new cases to double in the next 15 years.


Categories: Diabetes, Diabetes, Food, Insulin, Lipid Problems, Research, Type 1 Issues



You May Also Be Interested In...


Comments


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.